Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

Chemoprevention of tocotrienols: the mechanism of antiproliferative effects.

Wada S.

Forum Nutr. 2009;61:204-16. doi: 10.1159/000212752. Epub 2009 Apr 7. Review.

PMID:
19367124
2.

Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.

McAnally JA, Gupta J, Sodhani S, Bravo L, Mo H.

Exp Biol Med (Maywood). 2007 Apr;232(4):523-31.

PMID:
17392488
3.

Tumor suppressive effects of tocotrienol in vivo and in vitro.

Wada S, Satomi Y, Murakoshi M, Noguchi N, Yoshikawa T, Nishino H.

Cancer Lett. 2005 Nov 18;229(2):181-91. Epub 2005 Aug 10.

PMID:
16098658
4.
5.

Mechanisms mediating the antiproliferative and apoptotic effects of vitamin E in mammary cancer cells.

Sylvester PW, Shah SJ.

Front Biosci. 2005 Jan 1;10:699-709. Print 2005 Jan 1. Review.

PMID:
15569611
6.

Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells.

McIntyre BS, Briski KP, Gapor A, Sylvester PW.

Proc Soc Exp Biol Med. 2000 Sep;224(4):292-301.

PMID:
10964265
7.

Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway.

Shin-Kang S, Ramsauer VP, Lightner J, Chakraborty K, Stone W, Campbell S, Reddy SA, Krishnan K.

Free Radic Biol Med. 2011 Sep 15;51(6):1164-74. doi: 10.1016/j.freeradbiomed.2011.06.008. Epub 2011 Jun 21.

PMID:
21723941
8.

The 21st century form of vitamin E--tocotrienol.

Bardhan J, Chakraborty R, Raychaudhuri U.

Curr Pharm Des. 2011;17(21):2196-205. Review.

PMID:
21774783
9.

Tocotrienols and cardiovascular health.

Prasad K.

Curr Pharm Des. 2011;17(21):2147-54. Review.

PMID:
21774782
10.

Tocotrienol as a potential anticancer agent.

Ling MT, Luk SU, Al-Ejeh F, Khanna KK.

Carcinogenesis. 2012 Feb;33(2):233-9. doi: 10.1093/carcin/bgr261. Epub 2011 Nov 17. Review.

PMID:
22095072
11.

Multitargeted therapy of cancer by tocotrienols.

Nesaretnam K.

Cancer Lett. 2008 Oct 8;269(2):388-95. doi: 10.1016/j.canlet.2008.03.063. Epub 2008 May 27. Review.

PMID:
18504069
12.

[Progression of tocotrienols].

Sun W, Yan Y, Dong F.

Wei Sheng Yan Jiu. 2004 Mar;33(2):243-5. Review. Chinese.

PMID:
15209019
13.

Cancer preventive effects of vitamin E.

Wada S.

Curr Pharm Biotechnol. 2012 Jan;13(1):156-64. Review.

PMID:
21466429
14.

d-δ-Tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells.

Hussein D, Mo H.

Pancreas. 2009 May;38(4):e124-36. doi: 10.1097/MPA.0b013e3181a20f9c.

PMID:
19346993
15.

gamma-Tocotrienol induces mitochondria-mediated apoptosis in human gastric adenocarcinoma SGC-7901 cells.

Sun W, Xu W, Liu H, Liu J, Wang Q, Zhou J, Dong F, Chen B.

J Nutr Biochem. 2009 Apr;20(4):276-84. doi: 10.1016/j.jnutbio.2008.03.003. Epub 2008 Jul 7.

PMID:
18602811
16.

Tocotrienols inhibit human glutathione S-transferase P1-1.

van Haaften RI, Haenen GR, Evelo CT, Bast A.

IUBMB Life. 2002 Aug;54(2):81-4.

17.

Cellular protection and therapeutic potential of tocotrienols.

Catalgol B, Batirel S, Ozer NK.

Curr Pharm Des. 2011;17(21):2215-20. Review.

PMID:
21774780
18.

Tocotrienols induce apoptosis and autophagy in rat pancreatic stellate cells through the mitochondrial death pathway.

Rickmann M, Vaquero EC, Malagelada JR, Molero X.

Gastroenterology. 2007 Jun;132(7):2518-32. Epub 2007 Apr 12.

PMID:
17570223
20.

A redox-silent analogue of tocotrienol acts as a potential cytotoxic agent against human mesothelioma cells.

Kashiwagi K, Virgona N, Harada K, Kido W, Yano Y, Ando A, Hagiwara K, Yano T.

Life Sci. 2009 May 8;84(19-20):650-6. doi: 10.1016/j.lfs.2009.02.007. Epub 2009 Feb 14.

PMID:
19232361

Supplemental Content

Support Center